Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Tax Provisions (2024 - 2025)

Kiora Pharmaceuticals' Tax Provisions history spans 2 years, with the latest figure at -$667821.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 132.34% year-over-year to -$667821.0; the TTM value through Dec 2025 reached -$1.3 million, down 162.95%, while the annual FY2025 figure was -$1.3 million, 162.95% down from the prior year.
  • Tax Provisions reached -$667821.0 in Q4 2025 per KPRX's latest filing, down from -$643129.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.1 million in Q4 2024 to a low of -$667821.0 in Q4 2025.